| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 02/18/2014 | US8653268 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
| 02/18/2014 | US8653260 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists |
| 02/18/2014 | US8653259 Process for synthesizing heterocyclic compounds |
| 02/18/2014 | US8652752 Sulphonium salt initiators |
| 02/18/2014 | CA2716706C Compounds and compositions as tlr activity modulators |
| 02/18/2014 | CA2624492C Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
| 02/13/2014 | WO2014026125A1 Pyrazine derivatives as fgfr inhibitors |
| 02/13/2014 | WO2014024769A1 Method for synthesizing anti-anthradichalcogenophene |
| 02/13/2014 | US20140046055 Compounds and methods for inhibiting mitotic progression |
| 02/13/2014 | US20140045872 17a-HYDROXYLASE/C17,20-LYASE INHIBITORS |
| 02/13/2014 | US20140045865 2-amino-4-arylthiazole compounds as trpa1 antagonists |
| 02/13/2014 | US20140045849 Pyrimidine derivatives for the treatment of viral infections |
| 02/13/2014 | US20140045833 Protein Kinase Inhibitors |
| 02/13/2014 | US20140045821 Protein kinase d inhibitors |
| 02/12/2014 | EP2694518A1 Thieno [2, 3 -d]pyrimidine derivatives and their use to treat arrhythmia |
| 02/12/2014 | EP2694517A1 Protein kinase inhibitors |
| 02/12/2014 | EP2694515A1 Protein kinase inhibitors |
| 02/12/2014 | EP2694491A1 Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes |
| 02/12/2014 | EP2694476A1 Inhibitors of viral replication, their process of preparation and their therapeutical uses |
| 02/12/2014 | EP2694075A1 Phosphoinositide 3-kinase inhibitor with a zinc binding moiety |
| 02/12/2014 | EP2693882A1 Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment |
| 02/12/2014 | EP2693876A1 Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds |
| 02/12/2014 | CN103582482A Pharmaceutically active disubstituted triazine derivatives |
| 02/12/2014 | CN103570743A Soluble liquid machining two-dimensional conjugated organic molecular photovoltaic material as well as preparation method and application thereof |
| 02/12/2014 | CN103570742A Condensation compound and organic light emitting device including same |
| 02/12/2014 | CN103570741A Prasugrel novel crystals and preparation method thereof |
| 02/12/2014 | CN103570737A Heterocyclic compounds, organic light-emitting device comprising the same and organic light-emitting display |
| 02/12/2014 | CN103570735A Novel heterocyclic compounds and organic light emitting device comprising the same |
| 02/12/2014 | CN103570653A Heterocyclic compound, organic light-emitting device including the same , and organic light-emitting display device |
| 02/11/2014 | US8648081 Parasiticidal dihydroisoxazole compounds |
| 02/11/2014 | US8648068 Heterocycloalkyl-containing thienopyrimidines for pharmaceutical compositions |
| 02/11/2014 | CA2572121C Pyrimido-benzimidazole derivatives and the use thereof in the form of agonists or antagonists of melanocortin receptors |
| 02/06/2014 | WO2014019966A1 Functionalisation methods and reagents used in such methods using an azaisatoic anhydride or one of the derivatives of same, biological molecules thereby treated, and kits |
| 02/06/2014 | US20140038956 Use of sGC stimulators, sGC activators, alone and combinations with PDE5 inhibitors for the treatment of systemic sclerosis (SSc). |
| 02/06/2014 | US20140038924 Anti-Thrombotic Compounds |
| 02/06/2014 | DE102013206380A1 Verbindung und diese umfassende organische lichtemittierende Vorrichtung Connection and this comprehensive organic light emitting device |
| 02/05/2014 | CN103555322A Novel organic electroluminescent compounds and organic electroluminescent device using same |
| 02/05/2014 | CN103554958A Dithiophene pyrrole bridge-indoline organic dyes as well as preparation method and application thereof |
| 02/05/2014 | CN103554957A Triphenylamine-thiophene organic dyestuff as well as preparation method and application thereof |
| 02/05/2014 | CN103554132A Tetrahydrothieno-[2,3-c]pyridine deuterated derivatives and preparation method and medicament applications thereof |
| 02/05/2014 | CN103554131A Oxidized thieno-bi-carbazole derivative and applications thereof |
| 02/05/2014 | CN103554130A 2-(4-substituted benzoyl)-4,6-dibromo thiophene bithiophene and preparation method and application thereof |
| 02/05/2014 | CN103554129A Preparation method for biotin intermediate thioketone |
| 02/05/2014 | CN103554088A Benzodiazepine compound and pharmaceutical composition |
| 02/05/2014 | CN103554011A Anthracene containing derivative as well as preparation method and application thereof |
| 02/05/2014 | CN102604415B Preparation method of thiophene pyrazine dye and application thereof in dye sensitization solar battery |
| 02/04/2014 | US8642610 Dual small molecule inhibitors of cancer and angiogenesis |
| 02/04/2014 | US8642594 Substituted thieno[2,3-d]pyrimidines as HSP90 inhibitors |
| 01/30/2014 | WO2014016219A1 Dithienobenzofuran polymers and small molecules for electronic application |
| 01/30/2014 | US20140031386 Novel anti-platelet compound addition salt |
| 01/30/2014 | US20140031385 Therapeutic pyrazolyl thienopyridines |
| 01/30/2014 | US20140031378 Insecticidal spironindane derivatives |
| 01/30/2014 | US20140031320 Anti-Thrombotic Compounds |
| 01/30/2014 | US20140031302 Pochoxime conjugates useful for the treatment of hsp90 related pathologies |
| 01/30/2014 | DE102013214399A1 Heterocyclische Verbindungen und organische lichtemittierende Vorrichtungen, die diese aufweisen Heterocyclic compounds and organic light emitting devices having these |
| 01/30/2014 | DE102013202562A1 New heterocyclic compounds, useful in an organic LED of a flat panel display device, and as a fluorescent dopant and a phosphorescent host |
| 01/29/2014 | EP2689780A1 Intermediates for aminodihydrothiazine derivatives substituted with a cyclic group |
| 01/29/2014 | EP2078010B1 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 01/29/2014 | CN103547582A Compounds and polymers thereof containing fused thiophene rings for use in electronic applications |
| 01/29/2014 | CN103547581A Organic semiconductor material |
| 01/29/2014 | CN103547576A Parasiticidal dihydroisoxazole compounds |
| 01/29/2014 | CN102348702B Bi- and tricyclic indazole-substituted 1,4-dihydropyridine derivatives and uses thereof |
| 01/29/2014 | CN101402556B New compound 1-cyclopropyl-2-(2-fluorine phenyl)-2-hydroxyl ethanone, preparation method and application thereof |
| 01/29/2014 | CN101228154B Novel tetracyclic tetrahydrofuran derivatives containing a cyclic amine side chain |
| 01/28/2014 | US8637555 Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof |
| 01/28/2014 | US8637519 Heterocycle-substituted piperazino-dihydrothienopyrimidines |
| 01/28/2014 | CA2535265C Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 01/23/2014 | WO2014015291A1 FUSED PYRIMIDINES AS INHIBITORS OF p97 COMPLEX |
| 01/23/2014 | US20140024717 Process For The Preparation Of A Sulfated Derivative Of 3,5-Diiodo-O-[3-Iodophenyl]-L-Tyrosine |
| 01/23/2014 | US20140024662 Compounds, screens, and methods of treatment |
| 01/23/2014 | US20140024661 Fused pyrimidines and substituted quinazolines as inhibitors of p97 |
| 01/23/2014 | US20140024657 Small molecule inhibitors of necroptosis |
| 01/22/2014 | EP2687532A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these |
| 01/22/2014 | CN103534259A Conjugated polymers |
| 01/22/2014 | CN103524531A Organic photoelectric material, organic photoelectronic device and image sensor |
| 01/22/2014 | CN103524530A Prasugrel hydrobromide and preparation method thereof |
| 01/22/2014 | CN103524529A Synthetic method of intermediate of olanzapine |
| 01/22/2014 | CN103524528A Improved preparation method of II-type clopidogrel hydrogen sulfate crystal |
| 01/22/2014 | CN103524510A Novel organic electroluminescent compounds and organic electroluminescent device using the same |
| 01/22/2014 | CN103524481A Low bandgap dicyanovinyl and tricyanovinyl oligothiophenes for solar cell applications |
| 01/22/2014 | CN101906094B Preparation and application of novel antibacterial and anticancer compound and derivative thereof |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8633201 Thienopyrimidines having Mnk1/Mnk2 inhibiting activity for pharmaceutical compositions |
| 01/16/2014 | WO2014011906A2 Irak inhibitors and uses thereof |
| 01/16/2014 | US20140018357 Irak inhibitors and uses thereof |
| 01/16/2014 | US20140018343 Irak inhibitors and uses thereof |
| 01/16/2014 | US20140018331 Methods for the treatment or prophylaxis of thrombosis or embolism |
| 01/16/2014 | US20140018318 N1- and N2-CARBAMOYL-1,2,3-TRIAZOLE SERINE HYDROLASE INHIBITORS AND METHODS |
| 01/15/2014 | EP2684886A1 Chromene compound |
| 01/15/2014 | EP2683724A1 Asymmetric reduction process |
| 01/15/2014 | CN103509037A Preparation method of clopidogrel and intermediate thereof |
| 01/15/2014 | CN103509036A Novel fused ring compound and organic light-emitting device including the same |
| 01/15/2014 | CN103509035A Preparation method of clopidogrel hydrogen sulfate |
| 01/15/2014 | CN103509032A Batch green synthesis method of dioxaanthanthrene oxygenated fused ring compound |
| 01/15/2014 | CN103508980A Benzothiazine-4-one derivative, and preparation method and applications thereof |
| 01/15/2014 | CN102030760B Monomer with selected chromatic number and capacitor prepared by same |
| 01/14/2014 | US8628978 Responsive luminescent lanthanide complexes |
| 01/09/2014 | WO2014007299A1 Polythiophenes, water-soluble conductive polymer using same, and method for producing same |
| 01/09/2014 | WO2014005943A1 Process for preparing enantiomerically enriched oxamides |
| 01/09/2014 | WO2014005667A1 Conjugated polymers |